Publications

« 2006 »

• Countervailing effects of rapamycin (sirolimus) on nuclear factor­-kappa B activities in neointimal and medial smooth muscle cells.
  Dichtl W, Stocker EM, Mistlberger K, Debbage P, Yan ZQ, Alber HF, Frick M, Dulak J, Pachinger O, Weidinger F.
  Atherosclerosis. 2006 Jun;186(2):321-30.
  PMID: 16185698
• Cyclic AMP generating system in human microvascular endothelium is highly responsive to adrenaline.
  Namiecinska M, Wiktorowska-Owczarek A, Loboda A, Dulak J, Nowak JZ.
  Pharmacol Rep. 2006 Nov-Dec;58(6):884-9.
  PMID: 17220546
• Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.
  Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, Jozkowicz A.
  Am J Pathol. 2006 Dec;169(6):2181-98.
  PMID: 17148680
• Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.
  Potla R, Koeck T, Wegrzyn J, Cherukuri S, Shimoda K, Baker DP, Wolfman J, Planchon SM, Esposito C, Hoit B, Dulak J, Wolfman A, Stuehr D, Larner AC.
  Mol Cell Biol. 2006 Nov;26(22):8562-71.
  PMID: 16982690
• Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells.
  Funovics P, Brostjan C, Nigisch A, Fila A, Grochot A, Mleczko K, Was H, Weigel G, Dulak J, Jozkowicz A.
  Prostaglandins Other Lipid Mediat. 2006 May;79(3-4):230-44.
  PMID: 16647637
• Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.
  Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, Dulak J.
  Atherosclerosis. 2006 Jul;187(1):26-30.
  PMID: 16620829
• Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells.
  Gamero AM, Potla R, Wegrzyn J, Szelag M, Edling AE, Shimoda K, Link DC, Dulak J, Baker DP, Tanabe Y, Grayson JM, Larner AC.
  J Biol Chem. 2006 Jun 16;281(24):16238-44.
  PMID: 16601124
• Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.
  Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, Zagorska A, Sroczynska P, Drukala J, Jozkowicz A, Dulak J.
  Free Radic Biol Med. 2006 Apr 1;40(7):1250-63.
  PMID: 16545694
• Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.
  Loboda A, Jazwa A, Jozkowicz A, Molema G, Dulak J.
  Vascul Pharmacol. 2006 Apr;44(4):206-14.
  PMID: 16481221
• Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.
  Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Waś H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, Golab J.
  Oncogene. 2006 Jun 8;25(24):3365-74.
  PMID: 16462769
• New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes.
  Dulak J, Zagorska A, Wegiel B, Loboda A, Jozkowicz A.
  Cell Biochem Biophys. 2006;44(1):31-42. Review.
  PMID: 16456232